Caribou Biosciences (CRBU) Interest Coverage Ratio Growth (1y) (2021 - 2026)
Caribou Biosciences (CRBU) Interest Coverage Ratio Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,102.16 Bn | 67,101.87 Bn | - | -60.44% |
| 2 | Nanobiotix | 1,913.50 Bn | 1,913.44 Bn | - | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - | -347.04% |
| 4 | BeOne Medicines | 473.74 Bn | 468.95 Bn | 1.35 Bn | 787.12% |
| 5 | Vertex Pharmaceuticals | 122.07 Bn | 114.82 Bn | 2.59 Bn | 53.59% |
| 6 | Regeneron Pharmaceuticals | 70.00 Bn | 61.24 Bn | 3.31 Bn | -32.04% |
| 7 | Belite Bio | 62.34 Bn | 62.34 Bn | - | - |
| 8 | Argenx Se | 55.96 Bn | 50.77 Bn | 1.41 Bn | - |
| 9 | Alnylam Pharmaceuticals | 37.49 Bn | 34.48 Bn | 959.66 Mn | 1,378.45% |
| 10 | Caribou Biosciences | 155.78 Mn | 38.15 Mn | - | 98.89% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 98.89% |
| Dec 31, 2025 | -41.04% |
| Sep 30, 2025 | -881.94% |
| Jun 30, 2025 | -39,659.83% |
| Mar 31, 2025 | -123,295.09% |
| Dec 31, 2024 | -31.23% |
| Sep 30, 2024 | -3.26% |
| Jun 30, 2024 | -338.82% |
| Mar 31, 2024 | 96.06% |
| Dec 31, 2023 | -9.39% |
| Sep 30, 2023 | 12.51% |
| Jun 30, 2023 | -25.69% |
| Mar 31, 2023 | -18.91% |
| Dec 31, 2022 | -416.07% |
| Sep 30, 2022 | 78.36% |
| Jun 30, 2022 | 86.00% |
| Mar 31, 2022 | -1,588.53% |
| Dec 31, 2021 | 99.77% |
| Sep 30, 2021 | 99.63% |
| Jun 30, 2021 | 99.05% |